CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
BioDelivery Sciences (BDSI) is a specialty pharmaceutical company<br/><br/><br/><br/>that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partne...Show all
Company (IPO / Went public)
Phone: 919-582-9050
4131 ParkLake Avenue
Suite 225
Raleigh, 27612
North Carolina, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| BioDelivery Sciences International | $62M | Jun 26, 2018 |
| EyePoint Pharmaceuticals | $101.8M | Jan 4, 2021 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Transmucosal drug delivery devices for use in chronic pain relief | Dec 21, 2012 | Feb 27, 2018 | Patent |
| Transmucosal delivery devices with enhanced uptake | Jul 18, 2016 | May 23, 2017 | Patent |
| Transmucosal delivery devices with enhanced uptake | Jun 30, 2016 | Mar 21, 2017 | Patent |
| Abuse resistant transmucosal drug delivery device | Dec 13, 2006 | Dec 20, 2016 | Patent |
| Abuse-resistant mucoadhesive devices for delivery of buprenorphine | Aug 20, 2012 | Apr 22, 2014 | Patent |
